Bristlecone Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,249
| Closed | -$315K | – | 367 |
|
|
2024
Q2 | $315K | Buy |
3,249
+1
| +0% | +$92 | 0.03% | 226 |
|
|
2024
Q1 | $292K | Sell |
3,248
-299
| -8% | -$25.3K | 0.03% | 231 |
|
|
2023
Q4 | $283K | Buy |
3,547
+1
| +0% | +$75 | 0.03% | 233 |
|
|
2023
Q3 | $252K | Buy |
3,546
+1
| +0% | +$75 | 0.03% | 230 |
|
|
2023
Q2 | $273K | Buy |
3,545
+1
| +0% | +$77 | 0.03% | 230 |
|
|
2023
Q1 | $266K | Buy |
3,544
+811
| +30% | +$60.3K | 0.03% | 227 |
|
|
2022
Q4 | $215K | Buy |
+2,733
| New | +$205K | 0.03% | 246 |
|
|
2022
Q3 | – | Sell |
-2,711
| Closed | -$217K | – | 239 |
|
|
2022
Q2 | $217K | Buy |
2,711
+1
| +0% | +$78 | 0.03% | 231 |
|
|
2022
Q1 | $205K | Sell |
2,710
-24
| -0.9% | -$1.9K | 0.03% | 226 |
|
|
2021
Q4 | $233K | Sell |
2,734
-299
| -10% | -$23.3K | 0.03% | 216 |
|
|
2021
Q3 | $229K | Hold |
3,033
| – | – | 0.03% | 200 |
|
|
2021
Q2 | $247K | Sell |
3,033
-21,969
| -88% | -$1.8M | 0.03% | 193 |
|
|
2021
Q1 | $1.97M | Buy |
25,002
+90
| +0.4% | +$7.05K | 0.3% | 76 |
|
|
2020
Q4 | $2.13M | Sell |
24,912
-300
| -1% | -$24.8K | 0.34% | 71 |
|
|
2020
Q3 | $1.95M | Buy |
25,212
+87
| +0.3% | +$6.63K | 0.35% | 71 |
|
|
2020
Q2 | $1.84M | Buy |
25,125
+865
| +4% | +$61.4K | 0.37% | 71 |
|
|
2020
Q1 | $1.61M | Buy |
24,260
+184
| +0.8% | +$13K | 0.38% | 69 |
|
|
2019
Q4 | $1.66M | Buy |
24,076
+1,054
| +5% | +$71.9K | 0.33% | 79 |
|
|
2019
Q3 | $1.69M | Sell |
23,022
-634
| -3% | -$46K | 0.41% | 71 |
|
|
2019
Q2 | $1.7M | Buy |
23,656
+254
| +1% | +$18K | 0.4% | 66 |
|
|
2019
Q1 | $1.6M | Buy |
23,402
+585
| +3% | +$37.8K | 0.45% | 65 |
|
|
2018
Q4 | $1.36M | Sell |
22,817
-10,560
| -32% | -$661K | 0.41% | 71 |
|
|
2018
Q3 | $2.23M | Buy |
33,377
+10,665
| +47% | +$710K | 0.56% | 52 |
|
|
2018
Q2 | $1.47M | Sell |
22,712
-3,230
| -12% | -$211K | 0.49% | 54 |
|
|
2018
Q1 | $1.86M | Sell |
25,942
-8,288
| -24% | -$596K | 0.62% | 42 |
|
|
2017
Q4 | $2.58M | Sell |
34,230
-281
| -0.8% | -$20.5K | 0.82% | 35 |
|
|
2017
Q3 | $2.51M | Buy |
34,511
+1,790
| +5% | +$129K | 0.82% | 35 |
|
|
2017
Q2 | $2.43M | Buy |
32,721
+315
| +1% | +$23.4K | 0.82% | 38 |
|
|
2017
Q1 | $2.37M | Sell |
32,406
-1,450
| -4% | -$101K | 0.83% | 36 |
|
|
2016
Q4 | $2.22M | Sell |
33,856
-440
| -1% | -$30.2K | 0.79% | 37 |
|
|
2016
Q3 | $2.54M | Buy |
34,296
+1,310
| +4% | +$96.8K | 0.92% | 27 |
|
|
2016
Q2 | $2.42M | Buy |
32,986
+4,911
| +17% | +$350K | 0.89% | 38 |
|
|
2016
Q1 | $1.98M | Buy |
28,075
+4,420
| +19% | +$294K | 0.79% | 40 |
|
|
2015
Q4 | $1.58M | Buy |
+23,655
| New | +$1.57M | 0.67% | 48 |
|
Other funds holding CL
Bristlecone Advisors's CL Position: Q3 2024 in Review
Bristlecone Advisors sold out of Colgate-Palmolive (CL) in Q3 2024, closing a stake of 3,249 shares — an estimated $315K sold.
Bristlecone Advisors first reported a position in CL in Q4 2015 and held it in 34 quarters. The position peaked at $2.58M in Q4 2017. 1,909 funds tracked by Wall St. Rank hold CL as of Q3 2024.
- Bristlecone Advisors reported no remaining Colgate-Palmolive position as of Q3 2024 after selling out during the quarter.
- Bristlecone Advisors sold 3,249 Colgate-Palmolive shares in Q3 2024, an estimated $315K.
- Bristlecone Advisors first reported a position in Colgate-Palmolive in Q4 2015 and held it in 34 quarters.
- Bristlecone Advisors's Colgate-Palmolive position peaked at $2.58M in Q4 2017.
- 1,909 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.
Based on Bristlecone Advisors's 13F filing for Q3 2024, filed 24 Oct 2024.